Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Moschini

Showing results (541-550 of 561) with videos related to

Pageof 57
Sort By:
BJU International|March 21, 2024
How can we reduce morbidity after robot-assisted radical cystectomy with intracorporeal neobladder? A report on postoperative complications by the European Association of Urology Robotic Urology Section Scientific Working GroupFrancesco Pellegrino, Alberto Martini, Ugo Giovanni Falagario, et al.
Cancers|February 25, 2022
Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched AnalysisFrancesco Del Giudice, Rocco Simone Flammia, Benjamin I Chung, et al.
European Urology Oncology|February 14, 2024
Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non-muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk DynamicsJosé Daniel Subiela, Wojciech Krajewski, Daniel A González-Padilla, et al.
European Urology Focus|March 28, 2021
Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative StudyGautier Marcq, Beat Foerster, Mohammad Abufaraj, et al.
World Journal of Urology|January 11, 2026
Real-world outcomes of bladder-sparing strategies for BCG-unresponsive non-muscle-invasive bladder cancer: a multicenter studyPietro Scilipoti, Paolo Zaurito, Mattia Longoni, et al.
World Journal of Urology|October 6, 2022
Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium)Alessandro Tafuri, Michele Marchioni, Clara Cerrato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2025
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder CancerAndrea Necchi, Matthew D Galsky, Nazli Dizman, et al.
Minerva Urology and Nephrology|January 13, 2021
Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy SocietyGiancarlo Marra, Maria P Laguna, Jochen Walz, et al.
BJU International|March 3, 2026
Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groupsAna Fernández-Mardomingo, Jose Daniel Subiela, Alberto Artiles Medina, et al.
European Urology Oncology|June 17, 2022
Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder CancerLuca Afferi, Chiara Lonati, Francesco Montorsi, et al.
Pageof 57

Showing results (541-550 of 561) with videos related to

Sort By:
Pageof 57
BJU International|March 21, 2024
How can we reduce morbidity after robot-assisted radical cystectomy with intracorporeal neobladder? A report on postoperative complications by the European Association of Urology Robotic Urology Section Scientific Working GroupFrancesco Pellegrino, Alberto Martini, Ugo Giovanni Falagario, et al.
Cancers|February 25, 2022
Compared Efficacy of Adjuvant Intravesical BCG-TICE vs. BCG-RIVM for High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC): A Propensity Score Matched AnalysisFrancesco Del Giudice, Rocco Simone Flammia, Benjamin I Chung, et al.
European Urology Oncology|February 14, 2024
Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non-muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk DynamicsJosé Daniel Subiela, Wojciech Krajewski, Daniel A González-Padilla, et al.
European Urology Focus|March 28, 2021
Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative StudyGautier Marcq, Beat Foerster, Mohammad Abufaraj, et al.
World Journal of Urology|January 11, 2026
Real-world outcomes of bladder-sparing strategies for BCG-unresponsive non-muscle-invasive bladder cancer: a multicenter studyPietro Scilipoti, Paolo Zaurito, Mattia Longoni, et al.
World Journal of Urology|October 6, 2022
Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium)Alessandro Tafuri, Michele Marchioni, Clara Cerrato, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2025
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder CancerAndrea Necchi, Matthew D Galsky, Nazli Dizman, et al.
Minerva Urology and Nephrology|January 13, 2021
Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy SocietyGiancarlo Marra, Maria P Laguna, Jochen Walz, et al.
BJU International|March 3, 2026
Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groupsAna Fernández-Mardomingo, Jose Daniel Subiela, Alberto Artiles Medina, et al.
European Urology Oncology|June 17, 2022
Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder CancerLuca Afferi, Chiara Lonati, Francesco Montorsi, et al.
Pageof 57